LOPRAMAX

This brand name is authorized in Nigeria.

Active ingredients

The drug LOPRAMAX contains one active pharmaceutical ingredient (API):

1	Loperamide UNII 77TI35393C - LOPERAMIDE HYDROCHLORIDE
	By binding to opiate receptors in the gut wall, loperamide hydrochloride reduces propulsive peristalsis, increases intestinal transit time and enhances resorption of water and electrolytes. Loperamide increases the tone of the anal sphincter, which helps reduce faecal incontinence and urgency.
	Read more about Loperamide

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7560	Capsule	LOPRAMAX CAPSULES CAP 2 mg 10X1X10	54 RNW-PP-292754 LOPRAMAX CAPSULES LOPERAMIDE HYDROCHLORIDE BP 2MG EACH CAPSULE CONTAINS LOPERAMIDE HCL 2MG Lactose monohydrate Maize Starch Talc Magnesium Stearate B4-7560 Drugs Imported Products 10X1X10 Over The Counter (OTC) 11/16/2022 PATRICKLINGO PHARMACEUTICALS LIMITED, 18, Inno Uwakwe Street, Okwe Asaba 8033443825 patricklingopharm@outlook.com M/S GLOW PHARMA PVT. LTD, 26,27,28/2, SHANGRILLA IND. COMPLEX, CHINCHPADA, VASAI EAST, DISTRICT PAGHAR-401208, MAHASHRATA STATE, INDIA., India	27/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07DA03	Loperamide	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07D Antipropulsives → A07DA Antipropulsives
Discover more medicines within A07DA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7560